Law360, New York (August 11, 2008, 12:00 AM ET) -- Boston Scientific has announced it received a subpoena from the U.S. Department of Justice in connection with the agency's investigation of the marketing of bile-duct stents, less than a week after Johnson & Johnson subsidiary Cordis Corp. and Abbott Laboratories made similar announcements.
In its 10-Q form filed with the U.S. Securities and Exchange Commission on Friday, Boston Scientific said it received a subpoena in June from the U.S. attorney's office in Massachusetts.
The filing also said New Hampshire's attorney general subpoenaed Boston Scientific on July...
DOJ Targets Boston Scientific With Stent Subpoena
To view the full article, take a free trial now.
